Fidelity
Home > Boards > US Listed > Biotechs > Mast Therapeutics, Inc. (MSTX)

ANX i like this!! anyone see that gap

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
semipro11 Member Profile
Member Level 
Followed By 331
Posts 25,274
Boards Moderated 2
Alias Born 04/04/08
160x600 placeholder
Biotech Stocks Review -- Research on Achillion Pharma, Medivation, Mast Therapeutics, and Athersys "PR Newswire (US)" - 4/14/2014 8:16:00 AM
Mast Therapeutics Announces New Data Supporting MST-188 In Sickle Cell Disease "PR Newswire (US)" - 4/14/2014 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/26/2014 4:22:02 PM
Post-effective Amendment to Registration Statement (pos Am) "Edgar (US Regulatory)" - 3/26/2014 4:11:40 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 3/26/2014 8:46:20 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/26/2014 8:30:53 AM
Mast Therapeutics Reports Fourth Quarter And Full Year 2013 Financial Results "PR Newswire (US)" - 3/26/2014 8:15:00 AM
Mast Therapeutics Initiates Phase 2 Study Of MST-188 In Patients With Acute Limb Ischemia "PR Newswire (US)" - 3/26/2014 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/21/2014 4:45:35 PM
Active Stocks Coverage -- Research on Starbucks, Gerdau, Mast Therapeutics and Cia de Saneamento Basico do Estado "PR Newswire (US)" - 3/21/2014 10:28:00 AM
Purified Poloxamer Granted Unique Nonproprietary Name (Vepoloxamer) By U.S. Adopted Names Council "PR Newswire (US)" - 3/11/2014 8:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 2/28/2014 4:28:37 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/28/2014 4:16:34 PM
Vista Partners Updates Coverage on Mast Therapeutics, Inc. (NYSEMKT: MSTX); Price Target $2.25 "Marketwired" - 2/28/2014 9:00:00 AM
Mast Therapeutics Completes Acquisition Of Aires Pharmaceuticals, Inc. "PR Newswire (US)" - 2/27/2014 2:18:00 PM
Mast Therapeutics To Present At The Cowen & Co. 34th Annual Healthcare Conference On March 3rd "PR Newswire (US)" - 2/25/2014 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/24/2014 8:02:57 AM
Mast Therapeutics Announces International Expansion Of Phase 3 "EPIC" Study Of MST-188 "PR Newswire (US)" - 2/24/2014 8:00:00 AM
Mast Therapeutics Provides Additional Results From Nonclinical Heart Failure Study "PR Newswire (US)" - 2/18/2014 8:00:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/14/2014 2:18:21 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/14/2014 10:43:12 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/11/2014 5:12:21 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 2/10/2014 4:33:58 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/10/2014 8:16:11 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 2/10/2014 8:15:50 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist